Anh Tt Tan, MD
Family Practice · Honolulu
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 10 years
- Graduated 2016
Offices
1 location · Straub Clinic and Hospital · 420 clinicians in this group
Hospitals listed: 127310 · Pali Momi Medical Center · Straub Clinic and Hospital · The Queens Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Tan’s office at (808) 522-4000 to ask if they take your plan before you enroll.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Pali Momi Medical CenterAiea, HIAcute Care Hospital · Proprietary · Has an emergency departmentPart of Hawaii Pacific Health, which runs 4 hospitalsPatients rate it 4 of 5 · 79% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.166, Oct 2024 – Sep 2025
- Straub Clinic and HospitalHonolulu, HIAcute Care Hospital · Proprietary · Has an emergency departmentPart of Hawaii Pacific Health, which runs 4 hospitalsPatients rate it 4 of 5 · 75% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Postoperative respiratory failure rate: 16.47 (10.54 to 22.4) · 566 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.492, Oct 2024 – Sep 2025
- The Queens Medical CenterHonolulu, HIAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of The Queens Health Systems, which runs 4 hospitalsPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 3 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.34 (1.12 to 1.55), Jul 2022 – Jun 2024Worse than the national rate — Iatrogenic pneumothorax rate: 0.47 (0.29 to 0.65) · 11,638 cases, Jul 2022 – Jun 2024Worse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.32 (3.74 to 6.9) · 3,569 cases, Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 1.79 (1.36 to 2.23) · 10,444 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.453, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.427, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.345, Oct 2024 – Sep 2025
See every measure and the patient survey for Pali Momi Medical Center
Behind the star rating — Deaths: 1 better, 6 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 7 the same, 2 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.166 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.84 (0 to 1.82) · 823 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.44 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 162.97 (113.96 to 211.98) · 41 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.9 · 35 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.9 · 168 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 218 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 415 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 151 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.9 · 1,907 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.33 (0.12 to 0.54) · 3,322 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.03 to 0.44) · 3,332 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.79 (0.59 to 4.99) · 834 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.53 (0 to 3.19) · 216 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.18 (0.61 to 3.75) · 741 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 5.46 (0 to 13.24) · 243 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.89 (1.03 to 8.74) · 219 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.96 (0.48 to 3.43) · 267 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.42 (0 to 1.16) · 2,957 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.924 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.919 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.312 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.8 · 219 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.8 · 413 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 15.1 · 144 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 40.1 · 239 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -5.5 · 422 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.7 · 606 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.7 (4.5 to 9.6) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.6 (8.5 to 15.6) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 96 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.1 (9.2 to 16.3) · 578 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.5) · 387 cases | No different | Jan 2024 – Dec 2024 |
What patients said (419 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 80% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 65% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 59% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 54% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
See every measure and the patient survey for Straub Clinic and Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 5 the same, 1 worse of 7 measures. Readmissions: 2 better, 7 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Postoperative respiratory failure rateComplications and deaths | 16.47 (10.54 to 22.4) · 566 cases | Worse | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.492 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 2.02 (1.05 to 3) · 795 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.17 (0.85 to 1.48) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 157.42 (109.15 to 205.69) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 70 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.7 · 35 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 140 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.3 · 234 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 314 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 157 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 2,463 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.36) · 3,593 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.44) · 3,831 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.34 (2.2 to 6.48) · 1,181 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0.11 to 3.11) · 520 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.79 (2.28 to 5.3) · 1,005 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.85 (1.27 to 8.42) · 530 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.18 to 3.15) · 197 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.39 (0 to 1.11) · 3,199 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 52 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.416 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.63 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.359 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.502 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.5 · 270 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.2 · 381 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 11.2 · 172 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.8 · 261 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 6.2 · 314 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.2 · 561 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.9 (3.4 to 7.1) · 256 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.1 (8.2 to 15) · 256 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 63 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 68 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 63 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.4 (11 to 18.8) · 1,140 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.3) · 630 cases | No different | Jan 2024 – Dec 2024 |
What patients said (482 patients answered, 31% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 69% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 83% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 84% |
| Doctors "always" treated them with courtesy and respect | 88% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 75% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for The Queens Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 3 better, 3 the same, 2 worse of 8 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.34 (1.12 to 1.55) | Worse | Jul 2022 – Jun 2024 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.47 (0.29 to 0.65) · 11,638 cases | Worse | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.32 (3.74 to 6.9) · 3,569 cases | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.79 (1.36 to 2.23) · 10,444 cases | Worse | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.453 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.427 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.345 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0.12 to 1.78) · 2,583 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 181.61 (147.16 to 216.07) · 200 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.6 · 101 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 130 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.3 · 266 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 619 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.3 · 815 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 1,115 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 7,459 cases | None | Jul 2024 – Jun 2025 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.11 to 0.45) · 12,099 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.17 (0 to 2.44) · 1,411 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.9 (1.73 to 4.06) · 3,175 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.07 (2.95 to 11.2) · 1,400 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.22 (1.54 to 6.91) · 1,481 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.45 (0.06 to 2.83) · 821 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 163 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.751 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.143 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 501 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.2 · 1,438 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 10.8 · 272 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -5 · 698 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 15.4 · 799 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.4 · 1,657 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.6 (5.1 to 8.6) · 477 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.2 (9.1 to 13.9) · 477 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 171 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.4 · 122 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 17.5 · 353 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.6 (10 to 16.1) · 2,546 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 768 cases | No different | Jan 2024 – Dec 2024 |
What patients said (3,104 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 73% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 52% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$24,317
Medicare paid this office $24,317 for 114 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 89 | $10,714 | $63 |
| Short return visit (20+ min) | 39 | $3,153 | $53 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 103 | $2,620 | $12 |
| New patient visit (45+ min) | 14 | $1,238 | $88 |
| Influenza vaccine split virus, preservative free | 14 | $1,064 | $76 |
See all 6 services
| Return visit (30+ min) | 89 | $10,714 | $63 |
| Short return visit (20+ min) | 39 | $3,153 | $53 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 103 | $2,620 | $12 |
| New patient visit (45+ min) | 14 | $1,238 | $88 |
| Influenza vaccine split virus, preservative free | 14 | $1,064 | $76 |
| Administration of influenza virus vaccine | 13 | $436 | $34 |
Who their Medicare patients are
114 Original Medicare patients in 2024. Average age 76 · Women 57% · Also on Medicaid 10% · Health risk score 0.81. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 68% · Chronic kidney disease 31% · Diabetes 18% · Cancer 10%.
The office billed $104,128, Medicare allowed $34,779 and paid $24,317; for 555 services of 30 kinds; $2,224 of it was for drugs given in the office and $22,092 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 114 | 555 | 76 | 0.81 | $104,128 | $24,317 |
| 2023 | 97 | 259 | 77 | 0.79 | $66,304 | $15,222 |
| 2022 | 109 | 329 | 76 | 0.80 | $85,359 | $22,103 |
| 2021 | 58 | 160 | 73 | 0.99 | $37,521 | $9,880 |
| 2020 | 37 | 112 | 73 | 0.85 | $19,096 | $6,516 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Return visit (30+ min) | 62 | $5,971 | $63 |
| Short return visit (20+ min) | 41 | $2,672 | $47 |
| Telephone medical discussion with physician, 11-20 minutes | 14 | $806 | $58 |
| Administration of influenza virus vaccine | 12 | $385 | $32 |
2022: 6 services
| Return visit (30+ min) | 71 | $8,251 | $78 |
| Short return visit (20+ min) | 54 | $4,419 | $53 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 18 | $1,440 | $80 |
| Influenza vaccine split virus, preservative free | 12 | $813 | $68 |
| Administration of influenza virus vaccine | 20 | $644 | $32 |
| Administration of pneumococcal vaccine | 12 | $386 | $32 |
2021: 3 services
| Return visit (30+ min) | 23 | $1,711 | $57 |
| Short return visit (20+ min) | 18 | $1,392 | $46 |
| New patient visit (45+ min) | 14 | $1,226 | $88 |
2020: 1 service
| Short return visit (20+ min) | 17 | $1,505 | $56 |
Medicaid work
$3,910 in 2024
Medicaid paid $3,910 for 261 billed services this clinician did in 2024, up to 24 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 89 | $3,340 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 172 | $570 |
| 2024 | 261 | 2 | 24 | $3,910 |
| 2023 | 151 | 2 | 22 | $3,142 |
| 2022 | 292 | 2 | 27 | $7,927 |
| 2021 | 132 | 2 | 19 | $3,728 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 101 | $2,304 |
| Short return visit (20+ min) | 50 | $837 |
2022
| Short return visit (20+ min) | 180 | $3,970 |
| Return visit (30+ min) | 112 | $3,957 |
2021
| Return visit (30+ min) | 46 | $1,926 |
| Short return visit (20+ min) | 86 | $1,802 |
Drugs they prescribed that Part D paid
$260,267
Pharmacies billed $260,267 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (21 of 2,902) in 2024. At or below the middle of the specialty; the typical family practice clinician is at 2%.
2,650 generic and 237 brand-name prescriptions · $260,267 in drug cost · 37 antibiotic prescriptions to 27 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 40 | $54,985 | $1,375 |
| Eliquis | 16 | $24,776 | $1,548 |
| Januvia | 11 | $16,892 | $1,536 |
| Xarelto | 11 | $13,842 | $1,258 |
| Atorvastatin | 325 | $7,025 | $22 |
See all 58 drugs
| Jardiance | 40 | $54,985 | $1,375 |
| Eliquis | 16 | $24,776 | $1,548 |
| Januvia | 11 | $16,892 | $1,536 |
| Xarelto | 11 | $13,842 | $1,258 |
| Atorvastatin | 325 | $7,025 | $22 |
| Losartan | 195 | $3,054 | $16 |
| Symbicort | 12 | $3,034 | $253 |
| Lantus Solostar | 13 | $2,110 | $162 |
| Metoprolol | 89 | $2,104 | $24 |
| Rosuvastatin | 60 | $2,064 | $34 |
| Amlodipine Besylate | 158 | $1,697 | $11 |
| Tamsulosin | 82 | $1,660 | $20 |
| Alendronate | 77 | $1,421 | $18 |
| Lovastatin | 32 | $1,141 | $36 |
| Famotidine | 49 | $1,119 | $23 |
| Lisinopril | 102 | $1,039 | $10 |
| Omeprazole | 45 | $1,020 | $23 |
| Ezetimibe | 21 | $1,016 | $48 |
| Diclofenac | 20 | $989 | $49 |
| Pravastatin | 32 | $915 | $29 |
| Metformin | 79 | $817 | $10 |
| Valacyclovir | 15 | $806 | $54 |
| Pantoprazole | 25 | $776 | $31 |
| Pregabalin | 16 | $773 | $48 |
| Simvastatin | 56 | $763 | $14 |
| Gabapentin | 40 | $749 | $19 |
| Losartan-Hydrochlorothiazide | 18 | $683 | $38 |
| Modafinil | 13 | $628 | $48 |
| Levothyroxine | 85 | $561 | $7 |
| Donepezil | 17 | $495 | $29 |
| Fluticasone Propionate | 40 | $491 | $12 |
| Bupropion Xl | 18 | $473 | $26 |
| Duloxetine | 21 | $469 | $22 |
| Allopurinol | 24 | $460 | $19 |
| Trazodone | 37 | $407 | $11 |
| Azelastine | 13 | $401 | $31 |
| Albuterol Sulfate Hfa | 16 | $320 | $20 |
| Escitalopram | 25 | $316 | $13 |
| Irbesartan | 13 | $296 | $23 |
| Sertraline | 25 | $287 | $11 |
| Buspirone | 13 | $270 | $21 |
| Metformin Hcl Er | 19 | $258 | $14 |
| Glimepiride | 22 | $251 | $11 |
| Hydroxyzine | 11 | $247 | $22 |
| Montelukast | 14 | $238 | $17 |
| Atenolol | 14 | $229 | $16 |
| Finasteride | 15 | $228 | $15 |
| Metoprolol | 24 | $206 | $9 |
| Triamcinolone Acetonide | 29 | $200 | $7 |
| Clotrimazole | 12 | $158 | $13 |
| Hydrochlorothiazide | 36 | $155 | $4 |
| Clonidine | 12 | $136 | $11 |
| Carvedilol | 16 | $131 | $8 |
| Lidocaine Hcl Viscous | 13 | $130 | $10 |
| Meclizine | 12 | $105 | $9 |
| Furosemide | 18 | $91 | $5 |
| Propranolol | 13 | $87 | $7 |
| Prednisone | 13 | $29 | $2 |
Year by year
| 2024 | 2,902 | 390 | 1% (21) | 8% | $260,267 |
| 2023 | 2,554 | 355 | None | 8% | $221,826 |
| 2022 | 2,078 | 302 | None | 7% | $157,143 |
| 2021 | 1,271 | 156 | 2% (21) | None | $171,300 |
| 2020 | 645 | 101 | 3% (16) | 12% | $41,415 |
| 2019 | 212 | 60 | None | None | $29,890 |
| 2018 | 210 | 55 | 0% (0) | None | $16,863 |
| 2017 | 41 | 18 | 0% (0) | None | $1,699 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 48 drugs
| Eliquis | 28 | $28,977 | $1,035 |
| Jardiance | 15 | $24,272 | $1,618 |
| Atorvastatin | 329 | $6,766 | $21 |
| Losartan | 167 | $4,803 | $29 |
| Metoprolol | 92 | $2,504 | $27 |
| Rosuvastatin | 44 | $1,965 | $45 |
| Levothyroxine | 113 | $1,770 | $16 |
| Amlodipine Besylate | 128 | $1,611 | $13 |
| Tamsulosin | 74 | $1,214 | $16 |
| Alendronate | 60 | $1,062 | $18 |
| Modafinil | 12 | $942 | $79 |
| Duloxetine | 21 | $936 | $45 |
| Ezetimibe | 13 | $862 | $66 |
| Famotidine | 40 | $858 | $21 |
| Losartan-Hydrochlorothiazide | 13 | $839 | $65 |
| Metformin | 65 | $718 | $11 |
| Pregabalin | 13 | $715 | $55 |
| Diclofenac | 19 | $714 | $38 |
| Irbesartan | 11 | $572 | $52 |
| Fluticasone Propionate | 33 | $543 | $16 |
| Pantoprazole | 33 | $525 | $16 |
| Omeprazole | 38 | $518 | $14 |
| Albuterol Sulfate Hfa | 17 | $511 | $30 |
| Simvastatin | 48 | $511 | $11 |
| Lisinopril | 60 | $498 | $8 |
| Montelukast | 22 | $470 | $21 |
| Allopurinol | 21 | $464 | $22 |
| Lovastatin | 26 | $446 | $17 |
| Gabapentin | 27 | $402 | $15 |
| Pravastatin | 22 | $380 | $17 |
| Diltiazem 24hr Er (Cd) | 12 | $374 | $31 |
| Metformin Hcl Er | 27 | $361 | $13 |
| Buspirone | 16 | $307 | $19 |
| Metoprolol | 29 | $289 | $10 |
| Escitalopram | 24 | $277 | $12 |
| Sertraline | 19 | $237 | $12 |
| Bupropion Xl | 13 | $230 | $18 |
| Donepezil | 17 | $226 | $13 |
| Trazodone | 25 | $183 | $7 |
| Triamcinolone Acetonide | 18 | $157 | $9 |
| Clonidine | 13 | $125 | $10 |
| Glipizide | 12 | $123 | $10 |
| Lisinopril-Hydrochlorothiazide | 16 | $123 | $8 |
| Glimepiride | 12 | $110 | $9 |
| Furosemide | 16 | $99 | $6 |
| Hydrochlorothiazide | 24 | $93 | $4 |
| Warfarin | 16 | $40 | $3 |
| Lorazepam | 15 | $37 | $2 |
2022: 39 drugs
| Eliquis | 16 | $17,832 | $1,115 |
| Atorvastatin | 287 | $3,575 | $12 |
| Lidocaine | 11 | $2,184 | $199 |
| Rosuvastatin | 33 | $2,133 | $65 |
| Metoprolol | 65 | $1,780 | $27 |
| Losartan | 122 | $1,576 | $13 |
| Ezetimibe | 12 | $1,442 | $120 |
| Levothyroxine | 61 | $1,298 | $21 |
| Tamsulosin | 62 | $1,221 | $20 |
| Irbesartan | 14 | $759 | $54 |
| Alendronate | 43 | $732 | $17 |
| Gabapentin | 31 | $715 | $23 |
| Fluticasone Propionate | 40 | $692 | $17 |
| Amlodipine Besylate | 105 | $686 | $7 |
| Albuterol Sulfate Hfa | 16 | $684 | $43 |
| Omeprazole | 40 | $545 | $14 |
| Famotidine | 31 | $537 | $17 |
| Felodipine Er | 11 | $477 | $43 |
| Triamcinolone Acetonide | 22 | $427 | $19 |
| Allopurinol | 24 | $420 | $17 |
| Valacyclovir | 12 | $380 | $32 |
| Pravastatin | 18 | $374 | $21 |
| Pantoprazole | 26 | $299 | $12 |
| Montelukast | 15 | $284 | $19 |
| Lisinopril | 60 | $275 | $5 |
| Metformin | 43 | $255 | $6 |
| Donepezil | 15 | $253 | $17 |
| Simvastatin | 43 | $220 | $5 |
| Sertraline | 17 | $209 | $12 |
| Carvedilol | 15 | $180 | $12 |
| Diclofenac | 19 | $175 | $9 |
| Trazodone | 21 | $172 | $8 |
| Mupirocin | 12 | $160 | $13 |
| Hydrochlorothiazide | 23 | $145 | $6 |
| Atenolol | 13 | $124 | $10 |
| Metformin Hcl Er | 14 | $114 | $8 |
| Metoprolol | 15 | $46 | $3 |
| Naproxen | 11 | $44 | $4 |
| Glimepiride | 13 | $16 | $1 |
2021: 30 drugs
| Forteo | 13 | $52,548 | $4,042 |
| Eliquis | 15 | $20,172 | $1,345 |
| Jardiance | 11 | $14,570 | $1,325 |
| Lantus Solostar | 17 | $12,301 | $724 |
| Shingrix | 14 | $2,620 | $187 |
| Atorvastatin | 153 | $1,737 | $11 |
| Levothyroxine | 37 | $990 | $27 |
| Morphine Sulfate | 12 | $841 | $70 |
| Losartan | 59 | $791 | $13 |
| Metoprolol | 18 | $591 | $33 |
| Gabapentin | 34 | $516 | $15 |
| Famotidine | 20 | $508 | $25 |
| Omeprazole | 22 | $446 | $20 |
| Carvedilol | 11 | $290 | $26 |
| Amlodipine Besylate | 50 | $278 | $6 |
| Alendronate | 18 | $278 | $15 |
| Tamsulosin | 26 | $268 | $10 |
| Fluticasone Propionate | 17 | $262 | $15 |
| Lisinopril | 51 | $234 | $5 |
| Bupropion Xl | 14 | $216 | $15 |
| Trazodone | 15 | $186 | $12 |
| Glipizide Er | 14 | $180 | $13 |
| Simvastatin | 40 | $179 | $4 |
| Metformin Hcl Er | 16 | $176 | $11 |
| Allopurinol | 11 | $165 | $15 |
| Metformin | 38 | $137 | $4 |
| Diazepam | 13 | $125 | $10 |
| Metoprolol | 25 | $109 | $4 |
| Furosemide | 19 | $101 | $5 |
| Hydrochlorothiazide | 12 | $57 | $5 |
2020: 16 drugs
| Eliquis | 11 | $8,125 | $739 |
| Shingrix | 14 | $2,460 | $176 |
| Atorvastatin | 65 | $778 | $12 |
| Levothyroxine | 25 | $547 | $22 |
| Gabapentin | 28 | $471 | $17 |
| Omeprazole | 26 | $358 | $14 |
| Losartan | 16 | $336 | $21 |
| Fluticasone Propionate | 16 | $172 | $11 |
| Amlodipine Besylate | 29 | $158 | $5 |
| Carvedilol | 11 | $122 | $11 |
| Lisinopril | 29 | $98 | $3 |
| Metoprolol | 16 | $94 | $6 |
| Zolpidem | 12 | $68 | $6 |
| Metformin | 15 | $67 | $4 |
| Simvastatin | 16 | $49 | $3 |
| Furosemide | 11 | $49 | $4 |
2019: 2 drugs
| Gabapentin | 14 | $212 | $15 |
| Lisinopril | 25 | $119 | $5 |
2018: 4 drugs
| Gabapentin | 18 | $178 | $10 |
| Diclofenac | 12 | $159 | $13 |
| Lisinopril | 14 | $66 | $5 |
| Metformin | 12 | $60 | $5 |
Money from drug and device companies
$13 in 2023
A payment is not proof that care is biased.
| Janssen Pharmaceuticals | Xarelto | $13 | 1 payment
|
See the published payment
| Janssen Pharmaceuticals | Meals · 2023-08-30 | Xarelto | $13 |
Professional record
- NPI
- 1023469632
- Licence
- HI MD-20678
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X); Student in a training program (390200000X)
- Mailing address
- 1009 Kapiolani Blvd Apt 2112, Honolulu, HI, 96814
- NPI first listed
- 2016-06-24
- NPI last updated
- 2019-11-14
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 455 Oconnor Dr, San Jose, CA, 95128